Health
RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients – News-Medical.Net
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that it has acted on a request to provide opaganib treatment on an outpatient basis…
RedHill Biopharma Ltd. (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that it has acted on a request to provide opaganib treatment on an outpatient basis under compassionate use exemption for several Swiss patients suffering from COVID-19 pneumonia.
Acting rapidly to ensure emergency transport and supply of drug, treatment was initiated with orally-administered opaganib within the past week. Opaganib is a novel, orally-administered sphingosine kinase-2 (SK2)…
-
General19 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General20 hours agoTroops critically injured in Washington shooting named as FBI launch terror probe
-
Business19 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
-
General18 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting